SCHEDULE 13G/A 0001104659-24-007690 0001697748 XXXXXXXX LIVE 3 Class A Common Stock 12/31/2025 0001601830 Recursion Pharmaceuticals, Inc. 75629V104 41 S Rio Grande Street Salt Lake City UT 84101 Rule 13d-1(b) ARK Investment Management LLC DE 35278842.00 592161.00 37316856.00 0.00 37316856.00 N 7.25 IA Catherine D. Wood X1 0.00 35871003.00 0.00 37316856.00 37316856.00 N 7.25 HC IN Recursion Pharmaceuticals, Inc. 41 S Rio Grande Street Salt Lake City, UT, 84101 (i) ARK Investment Management LLC ("ARK") (ii) Catherine D. Wood ARK and Catherine D. Wood: 200 Central Avenue, St. Petersburg, FL 33701 (i) ARK: Delaware (ii) Catherine D. Wood: United States N IA HC ARK and Catherine D. Wood: 37,316,856 ARK and Catherine D. Wood: 7.25 (i) ARK: 35,278,842 (ii) Catherine D. Wood: 0 (i) ARK: 592,161 (ii) Catherine D. Wood: 35,871,003 (i) ARK: 37,316,856 (ii) Catherine D. Wood: 0 (i) ARK: 0 (ii) Catherine D. Wood: 37,316,856 Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. ARK Investment Management LLC /s/ Kellen Carter 02/03/2026 Catherine D. Wood /s/ Catherine D. Wood 02/03/2026